{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:08:22Z","timestamp":1767848902921,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,27]],"date-time":"2024-10-27T00:00:00Z","timestamp":1729987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.bbrep.2024.101860","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T13:06:31Z","timestamp":1730466391000},"page":"101860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Identification of hub genes and pathways in Uterine corpus endometrial carcinoma (UCEC): A comprehensive in silico study"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7043-1533","authenticated-orcid":false,"given":"Mahsa","family":"Ejlalidiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9621-5716","authenticated-orcid":false,"given":"Ameneh","family":"Mehri-Ghahfarrokhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6343-8518","authenticated-orcid":false,"given":"Mohammadreza","family":"Saberiyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.bbrep.2024.101860_bib1","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.2217\/fon.15.262","article-title":"Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma","volume":"11","author":"Rutgers","year":"2015","journal-title":"Future Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib2","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/s41467-018-05427-7","article-title":"Identification of nine new susceptibility loci for endometrial cancer","volume":"9","author":"O\u2019mara","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2024.101860_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bpobgyn.2018.08.004","article-title":"Challenges and controversies in the conservative management of uterine and ovarian cancer","volume":"55","author":"Janda","year":"2019","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"21","key":"10.1016\/j.bbrep.2024.101860_bib4","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1056\/NEJMra1514010","volume":"383","author":"Lu","year":"2020","journal-title":"Endometrial cancer. New England Journal of Medicine"},{"issue":"8","key":"10.1016\/j.bbrep.2024.101860_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrc1408","article-title":"Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms","volume":"4","author":"Calle","year":"2004","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib6","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1158\/1078-0432.CCR-15-0104","article-title":"Integrative protein-based prognostic model for early-stage endometrioid endometrial cancer","volume":"22","author":"Yang","year":"2016","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.bbrep.2024.101860_bib7","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41568-019-0177-x","article-title":"Clinical actionability of molecular targets in endometrial cancer","volume":"19","author":"Urick","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.bbrep.2024.101860_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.766947","article-title":"Identification of hub genes correlated with poor prognosis for patients with uterine corpus endometrial carcinoma by integrated bioinformatics analysis and experimental validation","volume":"11","author":"Yuan","year":"2021","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S1470-2045(18)30079-2","article-title":"Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial","volume":"19","author":"de Boer","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bbrep.2024.101860_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1146\/annurev-pathol-020117-043609","article-title":"Molecular genetics of endometrial carcinoma","volume":"14","author":"Bell","year":"2019","journal-title":"Annu. Rev. Pathol."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib12","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ygyno.2021.04.029","article-title":"Uterine serous carcinoma","volume":"162","author":"Bogani","year":"2021","journal-title":"Gynecol. Oncol."},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/path.4851","article-title":"Activated leukocyte cell adhesion molecule (ALCAM) is a marker of recurrence and promotes cell migration, invasion, and metastasis in early\u2010stage endometrioid endometrial cancer","volume":"241","author":"Devis","year":"2017","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.bbrep.2024.101860_bib14","doi-asserted-by":"crossref","first-page":"7635","DOI":"10.7314\/APJCP.2013.14.12.7635","article-title":"Sperm-associated antigen 9 is a promising marker for early diagnosis of endometrial cancer","volume":"14","author":"Baser","year":"2013","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.bbrep.2024.101860_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-016-2631-4","article-title":"L1CAM as a prognostic marker in stage I endometrial cancer: a validation study","volume":"16","author":"Smogeli","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2024.101860_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2407-13-616","article-title":"Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer","volume":"13","author":"Lenhard","year":"2013","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.bbrep.2024.101860_bib17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/bjc.2011.80","article-title":"Tetraspanin CD151 is a novel prognostic marker in poor outcome endometrial cancer","volume":"104","author":"Voss","year":"2011","journal-title":"Br. J. Cancer"},{"issue":"12","key":"10.1016\/j.bbrep.2024.101860_bib18","doi-asserted-by":"crossref","first-page":"22742","DOI":"10.1002\/jcp.28839","article-title":"Identification and validation of key genes associated with non\u2010small\u2010cell lung cancer","volume":"234","author":"Ma","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib19","doi-asserted-by":"crossref","first-page":"722","DOI":"10.3390\/ijms18040722","article-title":"Identification of key candidate genes and pathways in colorectal cancer by integrated bioinformatical analysis","volume":"18","author":"Guo","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2024.101860_bib20","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2147\/OTT.S158619","article-title":"Identification of key pathways and hub genes in basal-like breast cancer using bioinformatics analysis","author":"Yang","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib21","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/ijo.2020.5060","article-title":"Characterization of KIF20A as a prognostic biomarker and therapeutic target for different subtypes of breast cancer","volume":"57","author":"Nakamura","year":"2020","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib22","first-page":"205","article-title":"Bioinformatics analysis of RNA sequencing data reveals multiple key genes in uterine corpus endometrial carcinoma","volume":"15","author":"Shen","year":"2018","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib23","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/biom10020289","article-title":"Endoglin: beyond the endothelium","volume":"10","author":"Schoonderwoerd","year":"2020","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib24","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbadis.2008.01.006","article-title":"Role of transforming growth factor-\u03b2 superfamily signaling pathways in human disease","volume":"1782","author":"Gordon","year":"2008","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/156720111793663570","article-title":"Endoglin-targeted cancer therapy","volume":"8","author":"K Seon","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.bbrep.2024.101860_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10456-008-9101-9","article-title":"Endoglin in angiogenesis and vascular diseases","volume":"11","author":"Ten Dijke","year":"2008","journal-title":"Angiogenesis"},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14728222.2013.758716","article-title":"Endoglin for tumor imaging and targeted cancer therapy","volume":"17","author":"Paauwe","year":"2013","journal-title":"Expert Opin. Ther. Targets"},{"issue":"6","key":"10.1016\/j.bbrep.2024.101860_bib28","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.3390\/ijms22063186","article-title":"Endoglin in the spotlight to treat cancer","volume":"22","author":"Gonz\u00e1lez Mu\u00f1oz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2024.101860_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11912-013-0365-x","article-title":"Endoglin for targeted cancer treatment","volume":"16","author":"Rosen","year":"2014","journal-title":"Curr. Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/onc.2010.418","article-title":"Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma","volume":"30","author":"Pardali","year":"2011","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.bbrep.2024.101860_bib31","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/bjc.2015.302","article-title":"Identification of Endoglin as an epigenetically regulated tumour-suppressor gene in lung cancer","volume":"113","author":"O'Leary","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbrep.2024.101860_bib32","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/DAD.0b013e318252fc32","article-title":"Endoglin (CD105) and claudin-5 expression in cutaneous angiosarcoma","volume":"34","author":"Hara","year":"2012","journal-title":"Am. J. Dermatopathol."},{"issue":"12","key":"10.1016\/j.bbrep.2024.101860_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.2174\/1389201020666181127152605","article-title":"Expression profile of endoglin in different grades of endometrial cancer","volume":"19","author":"Op\u0142awski","year":"2018","journal-title":"Curr. Pharmaceut. Biotechnol."},{"issue":"8","key":"10.1016\/j.bbrep.2024.101860_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0072407","article-title":"Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors","volume":"8","author":"Breen","year":"2013","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.bbrep.2024.101860_bib35","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/ijc.23882","article-title":"Identification of an invasion and tumor\u2010suppressing gene, Endoglin (ENG), silenced by both epigenetic inactivation and allelic loss in esophageal squamous cell carcinoma","volume":"123","author":"Wong","year":"2008","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2024.101860_bib36","unstructured":"INVALID CITATION!!!."},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib37","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/dnares\/7.2.111","article-title":"Genomic characterization of the human heterotrimeric G protein \u03b1, \u03b2, and \u03b3 subunit genes","volume":"7","author":"Hurowitz","year":"2000","journal-title":"DNA Res."},{"issue":"3\u20134","key":"10.1016\/j.bbrep.2024.101860_bib38","doi-asserted-by":"crossref","first-page":"136","DOI":"10.18632\/genesandcancer.105","article-title":"Epigenetically silenced GNG4 inhibits SDF1\u03b1\/CXCR4 signaling in mesenchymal glioblastoma","volume":"7","author":"Pal","year":"2016","journal-title":"Genes & cancer"},{"issue":"10","key":"10.1016\/j.bbrep.2024.101860_bib39","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.7150\/jca.39539","article-title":"Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance","volume":"11","author":"Zhang","year":"2020","journal-title":"J. Cancer"},{"issue":"5","key":"10.1016\/j.bbrep.2024.101860_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41389-021-00330-1","article-title":"High expression of PSMC2 promotes gallbladder cancer through regulation of GNG4 and predicts poor prognosis","volume":"10","author":"Zhu","year":"2021","journal-title":"Oncogenesis"},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib41","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3233\/CBM-203009","article-title":"Identifying GNG4 might play an important role in colorectal cancer TMB","volume":"32","author":"Zhao","year":"2021","journal-title":"Cancer Biomarkers"},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib42","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3390\/genes13040693","article-title":"G-protein subunit gamma 4 as a potential biomarker for predicting the response of chemotherapy and immunotherapy in bladder cancer","volume":"13","author":"Duan","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.bbrep.2024.101860_bib43","first-page":"3024","article-title":"Identification of core genes and key pathways via integrated analysis of gene expression and DNA methylation profiles in bladder cancer","volume":"24","author":"Zhang","year":"2018","journal-title":"Med. Sci. Mon. Int. Med. J. Exp. Clin. Res.: international medical journal of experimental and clinical research"},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib44","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1533317517739384","article-title":"Neurotransmitter pathway genes in cognitive decline during aging: evidence for GNG4 and KCNQ2 genes","volume":"33","author":"Bonham","year":"2018","journal-title":"Am. J. Alzheimer's Dis. Other Dementias"},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib45","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1080\/21655979.2021.1952772","article-title":"Expression levels of chemokine (CXC motif) ligands CXCL1 and CXCL3 as prognostic biomarkers in rectal adenocarcinoma: evidence from Gene Expression Omnibus (GEO) analyses","volume":"12","author":"Lv","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.bbrep.2024.101860_bib46","series-title":"Identification of Hub Genes and Outcome in Colon Cancer Based on Bioinformatics Analysis","first-page":"323","author":"Yang","year":"2018"},{"issue":"5","key":"10.1016\/j.bbrep.2024.101860_bib47","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.cell.2009.08.017","article-title":"Heterogeneity in cancer: cancer stem cells versus clonal evolution","volume":"138","author":"Shackleton","year":"2009","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.bbrep.2024.101860_bib48","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.jhep.2015.01.014","article-title":"ECT2 regulates the Rho\/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma","volume":"62","author":"Chen","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.bbrep.2024.101860_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187356","article-title":"High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma","volume":"12","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bbrep.2024.101860_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006942","article-title":"A \u2018synthetic-sickness\u2019 screen for senescence re-engagement targets in mutant cancer backgrounds","volume":"13","author":"Cairney","year":"2017","journal-title":"PLoS Genet."},{"issue":"5","key":"10.1016\/j.bbrep.2024.101860_bib51","first-page":"1093","article-title":"Expression level of ECT2 proto-oncogene correlates with prognosis in glioma patients","volume":"16","author":"Sano","year":"2006","journal-title":"Oncol. Rep."},{"issue":"6419","key":"10.1016\/j.bbrep.2024.101860_bib52","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/362462a0","article-title":"Oncogene ect 2 is related to regulators of small GTP-binding proteins","volume":"362","author":"Miki","year":"1993","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib53","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1913054117","article-title":"Structure and regulation of human epithelial cell transforming 2 protein","volume":"117","author":"Chen","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"41","key":"10.1016\/j.bbrep.2024.101860_bib54","doi-asserted-by":"crossref","first-page":"3597","DOI":"10.1038\/onc.2009.217","article-title":"Ect2 links the PKC\u03b9\u2013Par6\u03b1 complex to Rac1 activation and cellular transformation","volume":"28","author":"Justilien","year":"2009","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib55","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1158\/1078-0432.CCR-08-1672","article-title":"Involvement of epithelial cell transforming sequence-2 oncoantigen in lung and esophageal cancer progression","volume":"15","author":"Hirata","year":"2009","journal-title":"Clin. Cancer Res."},{"issue":"11\u201312","key":"10.1016\/j.bbrep.2024.101860_bib56","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/1947601913514851","article-title":"The role of Ect2 nuclear RhoGEF activity in ovarian cancer cell transformation","volume":"4","author":"Huff","year":"2013","journal-title":"Genes & cancer"},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib57","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.ccell.2016.12.010","article-title":"Ect2-dependent rRNA synthesis is required for KRAS-TRP53-driven lung adenocarcinoma","volume":"31","author":"Justilien","year":"2017","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101036","article-title":"Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability","volume":"297","author":"Cao","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib59","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.advenzreg.2009.10.010","article-title":"The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer","volume":"50","author":"Fields","year":"2010","journal-title":"Adv. Enzym. Regul."},{"issue":"31","key":"10.1016\/j.bbrep.2024.101860_bib60","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1038\/onc.2013.362","article-title":"Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease","volume":"33","author":"Cook","year":"2014","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.bbrep.2024.101860_bib61","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1038\/ncb2129","article-title":"A small GTPase molecular switch regulates epigenetic centromere maintenance by stabilizing newly incorporated CENP-A","volume":"12","author":"Lagana","year":"2010","journal-title":"Nat. Cell Biol."},{"issue":"23","key":"10.1016\/j.bbrep.2024.101860_bib62","doi-asserted-by":"crossref","DOI":"10.7150\/thno.46878","article-title":"A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.bbrep.2024.101860_bib63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41416-019-0448-z","article-title":"ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer","volume":"120","author":"Daulat","year":"2019","journal-title":"Br. J. Cancer"},{"issue":"24","key":"10.1016\/j.bbrep.2024.101860_bib64","doi-asserted-by":"crossref","first-page":"8214","DOI":"10.1074\/jbc.RA120.013175","article-title":"Protein kinase C\u03b9 promotes UBF1\u2013ECT2 binding on ribosomal DNA to drive rRNA synthesis and transformed growth of non-small-cell lung cancer cells","volume":"295","author":"Justilien","year":"2020","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bbrep.2024.101860_bib65","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1093\/nar\/gkz1213","article-title":"ZRANB2 and SYF2-mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin","volume":"48","author":"Tanaka","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib66","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.molcel.2015.10.040","article-title":"Targeting the DNA damage response in cancer","volume":"60","author":"O'Connor","year":"2015","journal-title":"Mol. Cell"},{"issue":"6","key":"10.1016\/j.bbrep.2024.101860_bib67","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol. Cell"},{"issue":"42","key":"10.1016\/j.bbrep.2024.101860_bib68","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.18069","article-title":"Inhibition of extracellular matrix mediated TGF-\u03b2 signalling suppresses endometrial cancer metastasis","volume":"8","author":"Sahoo","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.bbrep.2024.101860_bib69","doi-asserted-by":"crossref","first-page":"73","DOI":"10.5603\/GP.2020.0020","article-title":"Increased osteopontin expression in endometrial carcinoma is associated with better survival outcome","volume":"91","author":"Al Maghrabi","year":"2020","journal-title":"Ginekol. Pol."},{"issue":"1","key":"10.1016\/j.bbrep.2024.101860_bib70","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/6793898","article-title":"Correlation of high\u2010risk human papilloma virus with deep endometriosis: a cross\u2010sectional study","volume":"2023","author":"Moslehi","year":"2023","journal-title":"BioMed Res. Int."},{"issue":"53","key":"10.1016\/j.bbrep.2024.101860_bib71","doi-asserted-by":"crossref","first-page":"7690","DOI":"10.1038\/sj.onc.1202953","article-title":"The role of the E6-p53 interaction in the molecular pathogenesis of HPV","volume":"18","author":"Thomas","year":"1999","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.bbrep.2024.101860_bib72","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1177\/1933719118799195","article-title":"Further evidence for hypercoagulability in women with ovarian endometriomas","volume":"25","author":"Ding","year":"2018","journal-title":"Reprod. Sci."},{"issue":"8","key":"10.1016\/j.bbrep.2024.101860_bib73","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3390\/diagnostics10080567","article-title":"Assessment of coagulation parameters in women affected by endometriosis: validation study and systematic review of the literature","volume":"10","author":"Ottolina","year":"2020","journal-title":"Diagnostics"},{"issue":"23","key":"10.1016\/j.bbrep.2024.101860_bib74","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1158\/1078-0432.CCR-14-1338","article-title":"Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer","volume":"20","author":"Suryawanshi","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.bbrep.2024.101860_bib75","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2741\/4431","article-title":"Inflammation and endometriosis","volume":"21","author":"Jiang","year":"2016","journal-title":"Front. Biosci."},{"issue":"4","key":"10.1016\/j.bbrep.2024.101860_bib76","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2005.05753.x","article-title":"The interactions between inflammation and coagulation","volume":"131","author":"Esmon","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrep.2024.101860_bib77","series-title":"Molecular Cell Biology","author":"Lodish","year":"2008"},{"key":"10.1016\/j.bbrep.2024.101860_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ceb.2016.02.013","article-title":"Adhesion protein networks reveal functions proximal and distal to cell-matrix contacts","volume":"39","author":"Byron","year":"2016","journal-title":"Curr. Opin. Cell Biol."},{"issue":"3","key":"10.1016\/j.bbrep.2024.101860_bib79","first-page":"1906","article-title":"Deregulation of cell adhesion molecules is associated with progression and poor outcomes in endometrial cancer: analysis of the Cancer Genome Atlas data","volume":"19","author":"He","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbrep.2024.101860_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108743","article-title":"A correlation study of adhesion G protein-coupled receptors as potential therapeutic targets in Uterine Corpus Endometrial cancer","volume":"108","author":"Lei","year":"2022","journal-title":"Int. Immunopharm."}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824002243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580824002243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T14:23:17Z","timestamp":1733235797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580824002243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":80,"alternative-id":["S2405580824002243"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101860","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of hub genes and pathways in Uterine corpus endometrial carcinoma (UCEC): A comprehensive in silico study","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2024.101860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101860"}}